Board Member
Maze Therapeutics, Inc. (MAZE)Equibles does not estimate personal net worth.
Get an email with a short summary when Maze Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get MAZE alertsJason Coloma is recorded as Board Member at Maze Therapeutics, Inc. (MAZE) since January 1, 2019 and CEO at Maze Therapeutics, Inc. (MAZE). The newest filing on record that lists Jason Coloma as CEO and Board Member at Maze Therapeutics, Inc. (MAZE) is dated April 28, 2026. Jason Coloma has spoken on 2 investor events across 1 company, most recently for Maze Therapeutics, Inc. on June 10, 2026. Maze Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Maze Therapeutics, Inc. includes Hervé Hoppenot (Chairman and Board Member), Misbah Tahir (CFO), Courtney Phillips (General Counsel) and 7 others.
“Yeah, so we are, if you will, a small molecule precision medicines company really focused on diseases that really haven't seen precision before, like kidney disease.”
“And first of all, I'd like to thank the Jefferies team for having us at this year's conference. I'd like to also acknowledge our forward-looking statements.”
2019-01-01–present
Last confirmed April 28, 2026
Start not stated–present
Last confirmed April 28, 2026
Biotechnology · Healthcare
CEO, Board Member
2019-01-01–present
